Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
Xiaolong Wei(Shantou University), Mazhar Adli(University of Virginia), Harun Öztürk(Northwestern University), Anindya Dutta(Indian Institute of Technology Bombay), Patrick E. O’Hara(University of Virginia), Cem Kuscu(University of Tennessee Health Science Center), Ebru Yilmaz(University of Virginia), Alaa Habieb(University of Virginia), Jiekun Yang(Rutgers, The State University of New Jersey), Sara J. Adair, Kyung Yong Lee(University of Virginia), Todd W. Bauer(University of Virginia), Denis Liu(University of Virginia), William J. Kane(Mayo Clinic in Arizona), Yusuf Mert Demirlenk(WinnMed)
Cited by 113
Related Papers
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project
|Nature|2007|5.3k
p21 in cancer: intricate networks and multiple activities
|Nature reviews. Cancer|2009|2.8k
DNA Replication in Eukaryotic Cells
|Annual Review of Biochemistry|2002|2k
MicroRNAs in Cancer
|Annual Review of Pathology Mechanisms of Disease|2008|1.6k
A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)
|Genes & Development|2009|1.2k